Kim, E.J.; Kim, Y.J.; Lee, H.I.; Jeong, S.-H.; Nam, H.J.; Cho, J.H.
Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus. Antioxidants 2020, 9, 1104.
https://doi.org/10.3390/antiox9111104
AMA Style
Kim EJ, Kim YJ, Lee HI, Jeong S-H, Nam HJ, Cho JH.
Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus. Antioxidants. 2020; 9(11):1104.
https://doi.org/10.3390/antiox9111104
Chicago/Turabian Style
Kim, Eui Joo, Yoon Jae Kim, Hye In Lee, Seok-Hoo Jeong, Hyo Jung Nam, and Jae Hee Cho.
2020. "Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus" Antioxidants 9, no. 11: 1104.
https://doi.org/10.3390/antiox9111104
APA Style
Kim, E. J., Kim, Y. J., Lee, H. I., Jeong, S.-H., Nam, H. J., & Cho, J. H.
(2020). Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus. Antioxidants, 9(11), 1104.
https://doi.org/10.3390/antiox9111104